234 related articles for article (PubMed ID: 35093072)
1. Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1).
Song P; Wusiman D; Li F; Wu X; Guo L; Li W; Gao S; He J
Cancer Cell Int; 2022 Jan; 22(1):49. PubMed ID: 35093072
[TBL] [Abstract][Full Text] [Related]
2. Spindle apparatus coiled-coil protein 1 (SPDL1) serves as a novel prognostic biomarker in triple-negative breast cancer.
Yang XY; Zheng XX; Zhai XJ; Tang T; Yu SC
Proteomics Clin Appl; 2024 Feb; ():e2300002. PubMed ID: 38316615
[TBL] [Abstract][Full Text] [Related]
3. SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer.
Klimaszewska-Wiśniewska A; Buchholz K; Durślewicz J; Villodre ES; Gagat M; Grzanka D
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163739
[TBL] [Abstract][Full Text] [Related]
4. GLIPR2: a potential biomarker and therapeutic target unveiled - Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.
Lin W; Zhang S; Gu C; Zhu H; Liu Y
Front Immunol; 2024; 15():1280525. PubMed ID: 38476239
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types.
Hu A; Wang Y; Tian J; Chen Z; Chen R; Han X; Chen Y; Liu T; Chen Q
Front Oncol; 2022; 12():947054. PubMed ID: 36505822
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers.
Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L
Front Oncol; 2022; 12():916907. PubMed ID: 35785154
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma.
Zhu A; Zong Y; Wei S; Li Y; Fan Y; Liu S; Gao X
J Cancer; 2023; 14(17):3351-3367. PubMed ID: 37928421
[TBL] [Abstract][Full Text] [Related]
8. SPDL1 Overexpression Is Associated With the 18F-FDG PET/CT Metabolic Parameters, Prognosis, and Progression of Esophageal Cancer.
Liu HS; Guo Q; Yang H; Zeng M; Xu LQ; Zhang QX; Liu H; Guo JL; Zhang J
Front Genet; 2022; 13():798020. PubMed ID: 35664322
[TBL] [Abstract][Full Text] [Related]
9. ERH Impacts Patient Prognosis and Tumor Immune Microenvironment: A Pan-Cancer Analysis.
Gong Q; Li Q; Shen X; Xu Z
Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38584561
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
11. Chromobox Homolog 8 (CBX8) in Human Tumor Carcinogenesis and Prognosis: A Pancancer Analysis Using Multiple Databases.
Shi D; Ao L; Yu H; Xia Y; Li J; Zhong W; Xia H
Front Genet; 2021; 12():745277. PubMed ID: 34567093
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of
Li L; Li F; Xu Z; Li L; Hu H; Li Y; Yu S; Wang M; Gao L
Front Pharmacol; 2023; 14():1213891. PubMed ID: 37680718
[No Abstract] [Full Text] [Related]
13. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity.
Ding JT; Yu XT; He JH; Chen DZ; Guo F
Front Genet; 2022; 13():912003. PubMed ID: 35783266
[No Abstract] [Full Text] [Related]
14. Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma.
Klimaszewska-Wiśniewska A; Buchholz K; Neska-Długosz I; Durślewicz J; Grzanka D; Zabrzyński J; Sopońska P; Grzanka A; Gagat M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670609
[TBL] [Abstract][Full Text] [Related]
15. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).
Gong S; Duan Y; Wu C; Osterhoff G; Schopow N; Kallendrusch S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576068
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
[TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer.
Chen J; Gao G; Li L; Ding J; Chen X; Lei J; Long H; Wu L; Long X; He L; Shen Y; Yang J; Lu Y; Sun Y
Front Genet; 2022; 13():817118. PubMed ID: 35601500
[No Abstract] [Full Text] [Related]
18. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.
Zhao H; Xie R; Zhang C; Lu G; Kong H
Front Genet; 2022; 13():989460. PubMed ID: 36159971
[No Abstract] [Full Text] [Related]
19. Integrated pan-cancer analysis reveals the immunological and prognostic potential of RBFOX2 in human tumors.
Huang F; Jin L; Zhang X; Wang M; Zhou C
Front Pharmacol; 2024; 15():1302134. PubMed ID: 38881877
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification.
Qiu Z; Xin M; Wang C; Zhu Y; Kong Q; Liu Z
J Oncol; 2022; 2022():8423173. PubMed ID: 35211173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
